186 related articles for article (PubMed ID: 28805579)
41. Hepatic features of Wilson disease.
Boga S; Ala A; Schilsky ML
Handb Clin Neurol; 2017; 142():91-99. PubMed ID: 28433114
[TBL] [Abstract][Full Text] [Related]
42. Clinical spectrum of Wilson's disease (hepatolenticular degeneration).
Dobyns WB; Goldstein NP; Gordon H
Mayo Clin Proc; 1979 Jan; 54(1):35-42. PubMed ID: 759736
[TBL] [Abstract][Full Text] [Related]
43. [Wilson's disease].
Kovacević I; Zekan M
Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
[TBL] [Abstract][Full Text] [Related]
44. [Wilson's disease: physiopathology, therapeutic approach and case report].
Gallo V; Riva P; Sidoli L; Bisbocci D
Minerva Gastroenterol Dietol; 1994 Dec; 40(4):197-201. PubMed ID: 7849148
[TBL] [Abstract][Full Text] [Related]
45. 99mTc-mebrofenin scintigraphy for evaluating liver disease in a rat model of Wilson's disease.
Malhi H; Bhargava KK; Afriyie MO; Volenberg I; Schilsky ML; Palestro CJ; Gupta S
J Nucl Med; 2002 Feb; 43(2):246-52. PubMed ID: 11850492
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive analysis on clinical features of Wilson's disease: an experience over 28 years with 133 cases.
Lin LJ; Wang DX; Ding NN; Lin Y; Jin Y; Zheng CQ
Neurol Res; 2014 Feb; 36(2):157-63. PubMed ID: 24107488
[TBL] [Abstract][Full Text] [Related]
47. Wilson disease.
Kitzberger R; Madl C; Ferenci P
Metab Brain Dis; 2005 Dec; 20(4):295-302. PubMed ID: 16382340
[TBL] [Abstract][Full Text] [Related]
48. Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease.
Piga M; Murru A; Satta L; Serra A; Sias A; Loi G; Marrosu F; Demelia L
Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):716-24. PubMed ID: 18180918
[TBL] [Abstract][Full Text] [Related]
49. [Wilson's disease].
Moilanen V; Mäkisalo H
Duodecim; 2010; 126(6):635-42. PubMed ID: 20597314
[TBL] [Abstract][Full Text] [Related]
50. Wilson's disease patients can be decoppered.
Walshe JM
Lancet; 1989 Jul; 2(8656):228. PubMed ID: 2568563
[No Abstract] [Full Text] [Related]
51. A review and update on the diagnosis and treatment of neuropsychiatric Wilson disease.
Cleymaet S; Nagayoshi K; Gettings E; Faden J
Expert Rev Neurother; 2019 Nov; 19(11):1117-1126. PubMed ID: 31314605
[No Abstract] [Full Text] [Related]
52. [Current principles of Wilson's disease--diagnosis and treatment].
Najda J; Stella-Hołowiecka B; Machalski M; Woszczyk D; Mykała-Cieśla J
Wiad Lek; 2002; 55(9-10):600-7. PubMed ID: 12607416
[TBL] [Abstract][Full Text] [Related]
53. Pathophysiology and treatment of Wilson's disease.
Tankanow RM
Clin Pharm; 1991 Nov; 10(11):839-49. PubMed ID: 1794220
[TBL] [Abstract][Full Text] [Related]
54. Brain microstructural abnormalities in patients with Wilson's disease: A systematic review of diffusion tenor imaging studies.
Karimi A; Mohammadi S; Salehi MA; Dager SR
Brain Imaging Behav; 2022 Dec; 16(6):2809-2840. PubMed ID: 36327021
[TBL] [Abstract][Full Text] [Related]
55. Delusional disorder and alcohol abuse in a patient with Wilson's disease.
Spyridi S; Diakogiannis I; Michaelides M; Sokolaki S; Iacovides A; Kaprinis G
Gen Hosp Psychiatry; 2008; 30(6):585-6. PubMed ID: 19061688
[TBL] [Abstract][Full Text] [Related]
56. [Hepatolenticular degeneration].
Zudenigo D; Relja M
Neurologija; 1990; 39(2):115-27. PubMed ID: 2267049
[TBL] [Abstract][Full Text] [Related]
57. Symptom aggravation after withdrawal of metal chelating agent therapy in patients with Wilson's disease.
Zhou X; Liao J; Liu Y; Qin H; Xiao X
Brain Behav; 2023 Sep; 13(9):e3170. PubMed ID: 37491953
[TBL] [Abstract][Full Text] [Related]
58. ARBM101 (Methanobactin SB2) Drains Excess Liver Copper via Biliary Excretion in Wilson's Disease Rats.
Einer C; Munk DE; Park E; Akdogan B; Nagel J; Lichtmannegger J; Eberhagen C; Rieder T; Vendelbo MH; Michalke B; Wimmer R; Blutke A; Feuchtinger A; Dershwitz P; DiSpirito AM; Islam T; Castro RE; Min BK; Kim T; Choi S; Kim D; Jung C; Lee H; Park D; Im W; Eun SY; Cho YH; Semrau JD; Rodrigues CMP; Hohenester S; Damgaard Sandahl T; DiSpirito AA; Zischka H
Gastroenterology; 2023 Jul; 165(1):187-200.e7. PubMed ID: 36966941
[TBL] [Abstract][Full Text] [Related]
59. Characteristics of neurological Wilson's disease without Kayser-Fleischer ring.
Youn J; Kim JS; Kim HT; Lee JY; Lee PH; Ki CS; Cho JW
J Neurol Sci; 2012 Dec; 323(1-2):183-6. PubMed ID: 23043908
[TBL] [Abstract][Full Text] [Related]
60. Other organ involvement and clinical aspects of Wilson disease.
Dzieżyc K; Litwin T; Członkowska A
Handb Clin Neurol; 2017; 142():157-169. PubMed ID: 28433099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
